Watch BLGO. Know when insiders buy.
One email the day a filing lands. Free.
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$3.7M | −$4M | — | -0.01 | −$3.1M | — | — | Aug 14 |
| Q1 2026 · Mar 31 | — | — | — | −$3.2M | −$3.4M | — | -0.01 | −$2.9M | — | — | May 15 |
| Q4 2025 · Dec 31derived | — | — | — | −$4M | −$4.1M | — | -0.01 | −$1.6M | — | — | Mar 4 |
| Q3 2025 · Sep 30 | — | — | — | −$7.2M | −$7.2M | — | -0.02 | −$2.8M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | — | — | — | −$1.8M | −$1.9M | — | -0.00 | −$2.1M | — | — | Aug 14 |
| Q1 2025 · Mar 31 | — | — | — | −$1.9M | −$1.9M | — | 0.00 | −$1.8M | — | — | May 15 |
| Q4 2024 · Dec 31derived | — | — | — | −$1.6M | −$1.7M | — | -0.01 | −$1.9M | — | — | Mar 4 |
| Q3 2024 · Sep 30 | — | — | — | −$1.1M | −$1.1M | — | -0.00 | −$1.6M | — | — | Nov 14 |
| Q2 2024 · Jun 30 | — | — | — | −$890K | −$780K | — | -0.00 | −$151K | — | — | Aug 14 |
| Q1 2024 · Mar 31 | — | — | — | −$763K | −$775K | — | -0.00 | $481K | — | — | May 15 |
| Q4 2023 · Dec 31derived | — | — | — | −$1M | −$1M | — | 0.00 | −$2K | — | — | Mar 31 |
| Q3 2023 · Sep 30 | — | — | — | −$1.5M | −$1.5M | — | -0.00 | −$836K | — | — | Nov 14 |
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$14.9M | −$15.2M | — | -0.04 | −$8.3M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$4.3M | −$4.3M | — | -0.01 | −$3.2M | — | — | — | — |
| FY2023 · to Dec 31 | $12.2M | 50.3% | −$4.6M | −$4.6M | -38.0% | -0.01 | −$2.4M | — | — | — | — |
| FY2022 · to Dec 31 | — | — | −$5.4M | −$5.1M | — | -0.02 | −$2.8M | — | — | — | — |
| FY2021 · to Dec 31 | — | — | −$6.8M | −$6.9M | — | -0.03 | −$3.9M | — | — | — | — |
| FY2020 · to Dec 31 | — | — | −$7.6M | −$9.7M | — | -0.05 | −$4.2M | — | — | — | — |
Every number comes from BIOLARGO, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.